Details for New Drug Application (NDA): 072722
✉ Email this page to a colleague
NDA 072722 describes ZOVIA 1/50E-21, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the ZOVIA 1/50E-21 profile page.
The generic ingredient in ZOVIA 1/50E-21 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
The generic ingredient in ZOVIA 1/50E-21 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
Summary for 072722
| Tradename: | ZOVIA 1/50E-21 |
| Applicant: | Watson Labs |
| Ingredient: | ethinyl estradiol; ethynodiol diacetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.05MG;1MG | ||||
| Approval Date: | Dec 30, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
